Sibutramine - A review of clinical efficacy

International Journal of Obesity

Volumn 21, Issue SUPPL. 1, 1997, Pages

  Lean, M E J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Clinical efficacy; Review; Sibutramine

Indexed keywords

CHOLESTEROL; DEXFENFLURAMINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIBUTRAMINE; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ANOREXIA; APPETITE DISORDER; ARTHROPATHY; BLOOD PRESSURE; BODY BUILD; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONSTIPATION; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; DYSMENORRHEA; EAR DISEASE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSOMNIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARESTHESIA; PRIORITY JOURNAL; SIDE EFFECT; SWEATING; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TENOSYNOVITIS; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION; VERTIGO; WEIGHT REDUCTION; XEROSTOMIA;

ANTI-OBESITY AGENTS; ANTIDEPRESSIVE AGENTS; APPETITE DEPRESSANTS; BODY WEIGHT; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; CLINICAL TRIALS; CYCLOBUTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; FENFLURAMINE; HUMANS; OBESITY; WEIGHT LOSS;

EID: 0030993522     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Williamson DF et al. Prospective study of intentional weight loss and mortality in never smoking US white women. Am J Epidemiol 1995; 141(12): 1128-1141.
2. Van Gaal L. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes (in press)
3. Perri MG, Nezu AM, Viegner BJ. Improving the Long Term Management of Obesity. Wiley Bioscience New York 1992;
4. Guy-Grand B et al. International trial of long-term dexfenfluramine in obesity. Lancet 1989; 2: 1142-1145.
5. Weintraub M. Long-term weight control study: conclusions. Clin Pharmacol Ther 1992; 51: 642-646.
6. Cole JO, Kaiser PE, DeHaan HA. Sibutramine hydrochloride: evaluation of abuse potential. Obes Res 1991; 1 (suppl 2): 71.
7. Kelly F, Jones SP, Lee IK. Sibutramine: weight loss in depressed patients. Int J Obes 1995; 19 (suppl 2) 145.
8. Jones SP, Newman BM, Romance FM. Sibutramine hydrochloride: weight loss in overweight subjects. Int J Obes 1994; 18 (suppl 2): 61.
9. Drouin P, Hanotin C, Coureier S, Leutenegger E. A dose ranging study: efficacy and tolerability of sibutramine in weight loss. Int J Obes 1994; 18 (suppl 2): 60.
10. Bray GA et al.. Sibutramine - dose response and long-term efficacy in weight loss. A double-blind study Int J Obes 1994; 18 (suppl 2): 60.
11. Jones SP, Smith IG, Kelly F, Gray JA. Long-term weight loss with sibutramine. Int J Obes 1995; 19 (suppl 2): 41.
12. Data on file: Knoll Pharmaceuticals, Nottingham, UK
13. Kelly F, Wade AG, Jones SP, Johnson SG. Sibutramine hydrochloride vs dexfenfluramine: weight loss in obese subjects. Int J Obes 1994; 18 (suppl 2): 61.
14. Griffiths J et al. Sibutramine in the treatment of overweight non-insulin dependent diabetics. Int J Obes 1995; 19 (suppl 2); 41.
15. Jung RT, Manning RM, Leese GP, Newton RW. The comparison of four weight reducing strategies aimed at overweight diabetic patients. Diabet Med 1995; 12: 409-415.
16. Blonk MC et al.. Influences of weight loss in type II diabetic patients: little long term benefit from group behaviour therapy and exercise training. Diab Med 1994; 11: 449-457.
17. Data on file: Knoll Pharmaceuticals, Nottingham, UK
18. Hazenberg BP, Johnson SG, Kelly F. Sibutramine in the treatment of obese subjects with hypertension. Int J Obes 1996; 20 (4): 156.